Publication:
Tumour lysis syndrome with acute renal failure during imatinib therapy

dc.contributor.buuauthorAli, Rıdvan
dc.contributor.buuauthorÖzkalemkaş, Fahir
dc.contributor.buuauthorÖzkan, Atilla
dc.contributor.buuauthorÖzçelik, Tülay
dc.contributor.buuauthorÖzkocaman, Vildan
dc.contributor.buuauthorAkdağ, İbrahim
dc.contributor.buuauthorOzan, Ülkü
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentNefroloji Ana Bilim Dalı
dc.contributor.departmentHematoloji Ana Bilim Dalı
dc.contributor.researcheridAAG-8495-2021
dc.contributor.researcheridAAH-1854-2021
dc.contributor.scopusid7201813027
dc.contributor.scopusid6601912387
dc.contributor.scopusid9250698600
dc.contributor.scopusid7005424333
dc.contributor.scopusid6603145040
dc.contributor.scopusid8342488100
dc.contributor.scopusid6507254632
dc.contributor.scopusid6602797853
dc.date.accessioned2022-09-16T12:18:50Z
dc.date.available2022-09-16T12:18:50Z
dc.date.issued2007-04
dc.identifier.citationAli, R. vd. (2007). "Tumour lysis syndrome with acute renal failure during imatinib therapy". Leukemia Research, 31(4), 573-574.
dc.identifier.endpage574
dc.identifier.issn0145-2126
dc.identifier.issn1873-5835
dc.identifier.issue4
dc.identifier.pubmed16782190
dc.identifier.scopus2-s2.0-33846702520
dc.identifier.startpage573
dc.identifier.urihttps://doi.org/10.1016/j.leukres.2006.05.005
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0145212606001639
dc.identifier.urihttp://hdl.handle.net/11452/28793
dc.identifier.volume31
dc.identifier.wos000244826600025
dc.indexed.scopusScopus
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherPergamon-Elsevier Science
dc.relation.journalLeukemia Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAcute renal failure
dc.subjectCancer
dc.subjectImatinib
dc.subjectLeukemia
dc.subjectTumour lysis syndrome
dc.subject.emtreeFurosemide
dc.subject.emtreeAllopurinol
dc.subject.emtreeAsparaginase
dc.subject.emtreeCalcium
dc.subject.emtreeCreatinine
dc.subject.emtreeCyclophosphamide
dc.subject.emtreeDaunorubicin
dc.subject.emtreeDiuretic agent
dc.subject.emtreeImatinib
dc.subject.emtreeRare disease
dc.subject.emtreeHemoglobin
dc.subject.emtreeHydroxyurea
dc.subject.emtreePhosphorus
dc.subject.emtreePriority journal
dc.subject.emtreeTumor lysis syndrome
dc.subject.emtreePrednisolone
dc.subject.emtreeUrea
dc.subject.emtreeUric acid
dc.subject.emtreeVincristine
dc.subject.emtreeAcute kidney failure
dc.subject.emtreePotassium
dc.subject.emtreeAdult
dc.subject.emtreeCancer combination chemotherapy
dc.subject.emtreeFatigue
dc.subject.emtreeCase report
dc.subject.emtreeChronic myeloid leukemia
dc.subject.emtreeDehydration
dc.subject.emtreeDrug effect
dc.subject.emtreeDrug withdrawal
dc.subject.emtreeDyspnea
dc.subject.emtreeHuman
dc.subject.emtreeLetter
dc.subject.emtreeMale
dc.subject.emtreePallor
dc.subject.emtreePetechia
dc.subject.emtreePurpura
dc.subject.emtreeRetreatment
dc.subject.emtreeTreatment outcome
dc.subject.meshHumans
dc.subject.meshAntineoplastic agents
dc.subject.meshKidney neoplasms
dc.subject.meshMiddle Aged
dc.subject.meshLeukemia, myeloid, chronic
dc.subject.meshKidney failure, acute
dc.subject.meshLeukemia, myeloid, philadelphia-positive
dc.subject.meshPiperazines
dc.subject.meshMale
dc.subject.meshProtein-tyrosine kinases
dc.subject.meshPyrimidines
dc.subject.meshTumor lysis syndrome
dc.subject.scopusTumor Lysis Syndrome; Rasburicase; Hyperphosphatemia
dc.subject.wosOncology
dc.subject.wosHematology
dc.titleTumour lysis syndrome with acute renal failure during imatinib therapy
dc.typeArticle
dc.wos.quartileQ2 (Hematology)
dc.wos.quartileQ3 (Oncology)
dc.wos.quartileQ2
dc.wos.quartileQ3
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Hematoloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Nefroloji Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: